Citadel Advisors’s SurgePays SURG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
Sell
-41,486
Closed -$61.2K 15530
2024
Q4
$73.8K Buy
+41,486
New +$73.1K ﹤0.01% 11890
2024
Q2
Sell
-3,558
Closed -$13.4K 15361
2024
Q1
$13.7K Buy
+3,558
New +$23.7K ﹤0.01% 13285
2023
Q4
Sell
-1,129
Closed -$6.01K 15226
2023
Q3
$5.28K Sell
1,129
-12,045
-91% -$62.5K ﹤0.01% 13411
2023
Q2
$96.3K Buy
+13,174
New +$78.5K ﹤0.01% 11001
2022
Q1
Sell
-13,584
Closed -$27K 14542
2021
Q4
$27K Buy
+13,584
New +$34.8K ﹤0.01% 13508

Other funds holding SURG

Citadel Advisors's SURG Position: Q1 2025 in Review

Citadel Advisors sold out of SurgePays (SURG) in Q1 2025, closing a stake of 41,486 shares — an estimated $61.2K sold.

Citadel Advisors first reported a position in SURG in Q4 2021 and held it in 5 quarters. The position peaked at $96.3K in Q2 2023. 29 funds tracked by Wall St. Rank hold SURG as of Q1 2025.

  • Citadel Advisors reported no remaining SurgePays position as of Q1 2025 after selling out during the quarter.
  • Citadel Advisors sold 41,486 SurgePays shares in Q1 2025, an estimated $61.2K.
  • Citadel Advisors first reported a position in SurgePays in Q4 2021 and held it in 5 quarters.
  • Citadel Advisors's SurgePays position peaked at $96.3K in Q2 2023.
  • 29 funds tracked by Wall St. Rank held SurgePays as of Q1 2025.

Based on Citadel Advisors's 13F filing for Q1 2025, filed 15 May 2025.